Multi-Drug Test Kits

What this page covers

This page covers multi-drug test kits, screening kits that test for more than one substance in a single test. The company's category pages list drug-of-abuse testing in saliva and urine formats. Ask whether a multi-drug kit is available and request its panel composition in writing. This page is a category page: it names the family and directs panel questions to written confirmation.

This site does not state how many substances any multi-drug kit screens for, and it does not list a panel composition for any kit, because no panel composition is evidenced in the company's own verified material. A buyer needing a panel list must name the kit and ask for its panel composition to be confirmed in writing.

How buyers usually compare multi-drug kits

Buyers comparing multi-drug kits usually ask about sample format, panel composition, packing configurations, shelf life and instruction languages. Sample format matters because a multi-drug kit may be a saliva kit or a urine kit, and the two formats are covered on their own pages. Panel composition is the decisive question for most buyers, and it is the question this page cannot answer from published evidence, so it must be confirmed in writing for the specific kit.

As with all drug test kits on this site, multi-drug kits are screening tests. A screening result is a preliminary indication that is normally followed by confirmatory testing in professional settings. This page does not describe any multi-drug kit as a definitive or legal conclusion about any individual, and it publishes no threshold values.

Ordering notes

The company FAQ states that prices vary with supply and market factors, that international orders are subject to an ongoing minimum order requirement with no fixed figure published, that samples take about 7 days, and that mass production takes 20–30 days after deposit. Certificates are available upon request. Before payment, confirm panel composition and current terms in writing for the specific kit.

Why panels matter more than formats

For multi-drug kits, panel composition matters more than sample format. Two multi-drug kits can share a sample format and a price range yet screen for entirely different substance sets, and a buyer who orders by format alone risks stocking a kit that does not match its customers' screening policies. That is why this site refuses to publish a panel composition it cannot evidence: a guessed panel is worse than an absent panel, because it misleads procurement decisions.

A buyer should therefore start from the screening policy: which substances must be screened, in which sample format, and under what programme rules. Then the buyer should name the kit and ask for its panel composition to be confirmed in writing against that policy, before any order is placed.

Single-test convenience and its limits

The convenience of a multi-drug kit is that one test run screens for more than one substance, which saves sample, time and handling compared with running separate single-substance tests. That convenience has a limit: a multi-drug kit's panel is fixed, and a substance outside the panel is not screened by that kit at all. A buyer whose policy covers a substance outside a kit's panel needs a different kit or an additional test, and that gap should be found during written confirmation, not after delivery.